Robert Screaton
PhD
Robert Screaton received his undergraduate and graduate training at McGill University in Montreal, Canada (1998), and pursued post-doctoral studies at the Burnham Institute (1999- 2002) and the Salk Institute (2002-2005) in San Diego, California. Dr. Screaton joined the Children’s Hospital of Eastern Ontario Research Institute and the University of Ottawa in July 2005 where he is now Senior Scientist and Associate Professor. Dr Screaton’s research focuses on the function and survival of pancreatic beta cells, cells that produce the hormone insulin and which either stop working or die off, leading to diabetes. Dr. Screaton is also the co-director of the CHEO-RI robotic cell based screening facility, and the recipient of awards such as the Canada Research Chair In Apoptotic Signaling, Tier II (2006-2016) and Ontario Early Researcher Award, the CHEO Research Institute’s Outstanding New Investigator Award and the University of Ottawa Faculty of Medicine’s Young Professor Award.